Tag: BX1000
Positive findings from the second interim analysis of the phase 2 randomised trial for BX1000 are reported by Baudax Bio.
The second preplanned interim analysis of Baudax Bio, Inc.’s phase 2 trial of BX1000 for neuromuscular blockade (NMB)…
Registration Form
This will close in 0 seconds
